期刊文献+

Characteristic roadmap of linker governs the rational design of PROTACs

原文传递
导出
摘要 Proteolysis targeting chimera (PROTAC) technology represents a groundbreaking development in drug discovery, leveraging the ubiquitin‒proteasome system to specifically degrade proteins responsible for the disease. PROTAC is characterized by its unique heterobifunctional structure, which comprises two functional domains connected by a linker. The linker plays a pivotal role in determining PROTAC's biodegradative efficacy. Advanced and rationally designed functional linkers for PROTAC are under development. Nonetheless, the correlation between linker characteristics and PROTAC efficacy remains under-investigated. Consequently, this study will present a multidisciplinary analysis of PROTAC linkers and their impact on efficacy, thereby guiding the rational design of linkers. We will primarily discuss the structural types and characteristics of PROTAC linkers, and the optimization strategies used for their rational design. Furthermore, we will discuss how factors like linker length, group type, flexibility, and linkage site affect the biodegradation efficiency of PROTACs. We believe that this work will contribute towards the advancement of rational linker design in the PROTAC research area.
出处 《Acta Pharmaceutica Sinica B》 SCIE CAS CSCD 2024年第10期4266-4295,共30页 药学学报(英文版)
基金 supported by the National Natural Science Foundation of China(No.32125033,32260688,China) Innovation and Entrepreneurship Project for Overseas Talents in Guizhou Province(No.[2022]03,China) Specific Natural Science Foundation of Guizhou University(No.[2022]42,China) the Central Government Guides Local Science and Technology Development Fund Projects(Qiankehezhongyindi(2023)001,China).
  • 相关文献

参考文献9

二级参考文献28

共引文献120

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部